Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Am Acad Child Adolesc Psychiatry. 2013 Jul 25;52(10):10.1016/j.jaac.2013.07.008. doi: 10.1016/j.jaac.2013.07.008

Altered Cerebral Perfusion in Executive, Affective, and Motor Networks During Adolescent Depression

Tiffany C Ho 1, Jing Wu 2, David D Shin 3, Thomas T Liu 4, Susan F Tapert 5, Guang Yang 6, Colm G Connolly 7, Guido KW Frank 8, Jeffrey E Max 9, Owen Wolkowitz 10, Stuart Eisendrath 11, Fumiko Hoeft 12, Dipavo Banerjee 13, Korey Hood 14, Robert L Hendren 15, Martin P Paulus 16, Alan N Simmons 17, Tony T Yang 18
PMCID: PMC3825460  NIHMSID: NIHMS510914  PMID: 24074474

Abstract

Objective

While substantial literature has reported regional cerebral blood flow (rCBF) abnormalities in adults with depression, these studies commonly necessitated the injection of radioisotopes into subjects. The recent development of arterial spin labeling (ASL), however, allows for noninvasive measurements of rCBF. Currently, no published ASL studies have examined cerebral perfusion in adolescents with depression. Thus, the aim of the present study was to examine baseline cerebral perfusion in adolescent depression using a newly developed ASL technique: pseudocontinuous arterial spin labeling (PCASL).

Method

25 medication-naive adolescents (ages 13–17 years) diagnosed with major depressive disorder (MDD) and 26 well-matched controls underwent functional magnetic resonance imaging. Baseline rCBF was measured via a novel PCASL method that optimizes tagging efficiency.

Results

Voxel-based whole brain analyses revealed significant frontal, limbic, paralimbic, and cingulate hypoperfusion in the group with depression (p<0.05, corrected). Hyperperfusion was also observed within the subcallosal cingulate, putamen, and fusiform gyrus (p<0.05, corrected). Similarly, region-of-interest analyses revealed amygdalar and insular hypoperfusion in the group with depression, as well as hyperperfusion in the putamen and superior insula (p<0.05, corrected).

Conclusions

Adolescents with depression and healthy adolescents appear to differ on rCBF in executive, affective, and motor networks. Dysfunction in these regions may contribute to the cognitive, emotional, and psychomotor symptoms commonly present in adolescent depression. These findings point to possible biomarkers for adolescent depression that could inform early interventions and treatments and establishes a methodology for using PCASL to noninvasively measure rCBF in clinical and healthy adolescent populations.

Keywords: cerebral blood flow, functional magnetic resonance imaging (fMRI), major depressive disorder (MDD), pseudocontinuous arterial spin labeling (PCASL)

Introduction

Major depressive disorder (MDD) is associated with significant morbidity and mortality, and is one of the leading causes of disability in the United States,1 with incidence rates rising dramatically after puberty.2 The estimated lifetime prevalence of MDD in adolescents is over 15%,3 with a two- to fourfold risk of depression continuing into adulthood.4 Given the severity and pervasiveness of this disorder, understanding the underlying neural mechanisms involved in adolescent MDD is critical to developing early interventions and improving current treatments.

Functional neuroimaging studies have provided key insights into the neurobiological circuitry of MDD. Much of this earlier work measured baseline cerebral blood flow (CBF) and glucose metabolism using positron emission tomography (PET) and single photon emission computer tomography (SPECT) in adults with depression.59 Both PET and SPECT, however, are highly invasive, less widely available, and notable more expensive due to having radioactive material as imaging agents, thus making these methods not appropriate for pediatric psychiatry research.10 Consequently, functional magnetic resonance imaging (fMRI) utilizing blood oxygenation level dependent (BOLD) and arterial spin labeling (ASL) techniques has become an increasingly popular tool for noninvasively measuring brain activation in neuropsychiatric populations (for reviews on these two methods, see Detre et al., 2009;11 Greicius, 2008;12 Brown et al., 2007;13 Fox and Raichle, 200714).

Resting state fMRI studies of adults with depression1521 and adolescents2123 have examined functional connectivity patterns (i.e., temporal correlations in blood-oxygen-level-dependent [BOLD] signal) among brain regions during periods of rest. In these studies, adult MDD appears to be associated with altered functional connectivity in fronto-limbic,19 fronto-striatal,16 cingulate-limbic,15,17,18,21 and limbic-paralimbic20 networks. Similarly, resting state functional connectivity studies in adolescents2123 with MDD have observed aberrant connectivity between portions of the subcallosal cingulate and prefrontal,2123 limbic, and paralimbic sites.22, 23 These results suggest that MDD is an illness with a distributive effect over the executive and affective networks of the brain. However, while functional connectivity analyses of BOLD resting state data can be used to identify intrinsic networks of the brain and how connective strengths within and across such networks change with depression,12,14 these assessments are nevertheless based on correlations between BOLD time series.10,12 The BOLD signal itself is a relative measure that is also dependent on vascular factors such as blood flow and blood volume, which can further confound interpretation.10 Thus, even though BOLD resting state functional connectivity can reveal which correlations between brain regions or networks may be abnormal in patients with depression, it cannot provide in absolute, physiological terms which brain regions specifically are dysfunctional during depression.10,12,24

The ASL signal, on the other hand, is derived from the subtraction of tagged (via magnetically labeled arterial water) and control images that is directly proportional to perfusion changes (for reviews on ASL methodology, see Detre and Wang, 2002;10 Bokkers et al., 2010;25 Borogovac and Asllani, 201226). Hence, one methodological advantage of ASL over BOLD techniques is that it can provide an absolute estimate of regional CBF (rCBF) in physiological units (milliliters of blood per 100 grams of tissue per minute).11,25 The benefit of obtaining an absolute physiological measurement like rCBF is that it could complement brain measures from other imaging modalities, such as BOLD fMRI, which are sensitive to blood flow. Additionally, perfusion patterns hold promise as objective biomarkers for tracking illness progression, pharmacological effects, and developmental brain maturation in a variety of neuropsychiatric and developmental disorders.13,26 Assessing whether rCBF patterns deviate significantly from the norm in at-risk groups could also potentially aid in early diagnosis, intervention, and prevention.27 Moreover, several of the working models of adult depression that have led to the advancement of innovative treatments are based on PET studies.6,2832 It is therefore important to compare these findings with analogous measures in youth with depression to generate similar models that could lead to the development of further treatment options for adolescent MDD. Thus, the ability of ASL to quantify an absolute physiological measurement like PET,11,25 yet to do so noninvasively makes it an exceptionally powerful tool for investigating brain differences between pediatric psychiatric and healthy populations.10

To our knowledge, there are currently no ASL-based studies examining cerebral perfusion in adolescent depression. ASL studies of adult MDD have noted perfusion differences in fronto-limbic-cingulate-striatal networks, but have reported both increased and attenuated rCBF perfusion, particularly in the limbic, paralimbic, and striatal areas.3336 These disparate results are further complicated by the fact that these studies recruited primarily medicated patients.3336 Different antidepressants could have augmenting or abating effects on rCBF, hence obscuring inferences about the baseline perfusion profiles of MDD.3738 Applying ASL techniques in medication-naïve individuals with depression may therefore help resolve the inconsistencies in the extant literature and determine whether hyper- or hypoperfusion is indeed a potential biomarker of adolescent MDD.

Our study was therefore designed to compare rCBF patterns in a sizeable group of nonmedicated MDD and well-matched healthy control (HCL) adolescents. The current study is notable for at least three reasons. Firstly, this is at present the only ASL study of adolescent depression. Secondly, all of the adolescents with depression in our study met full criteria for MDD, were medication naïve, and were diagnosed with minimal comorbidities at the time of scanning. Lastly, we employed a novel ASL method— pseudocontinuous arterial spin labeling (PCASL)—that optimizes tagging efficiency,39 yields relatively high quality CBF images, and is capable of being implemented on clinical scanners.40,41 We conducted a voxel-based whole brain analysis in order to compare rCBF levels between both groups. Given the contrary perfusion results within the limbic, paralimbic, and striatal regions in studies on adults with depression,59, 1518 we also performed a region-of-interest (ROI) analysis specifically targeting the amygdala, insula, and striatum. These structures have been shown in a variety of fMRI studies4245 to be heavily involved in affective processing and emotional regulation, and as such, theorized to be principal nodes within network models of depression and thus, motivating our ROI analyses.7

Despite developmental differences between adults and adolescents, clinical and neurobiological studies have suggested some continuity between adolescent and adult MDD.46 Given the current paucity of perfusion studies on adolescent MDD, our hypotheses are driven primarily by PET and ASL work in adult depression.59,3336 Based on these data, MDD is thought to be characterized by abnormalities in frontal areas supporting executive functioning and in limbic, paralimbic, and cingulate regions supporting affective processing7—particularly, the amygdala, insula, and anterior and subcallosal cingulate—with the most consistent findings across the literature being abnormal frontal hypoperfusion and subcallosal cingular hyperperfusion in MDD.59, 3336 We therefore hypothesized that these areas would exhibit significant differences in rCBF levels between MDD and HCL adolescents and more specifically, that adolescents with MDD would exhibit frontal hypoperfusion and subcallosal cingular hyperperfusion.

Method

Subjects

Fifty-one right-handed adolescents (ages 13–17 years old) participated in the study: 25 adolescents with a current primary DSM-IV diagnosis of MDD (age: Mean ± SD: 15.98 ± 1.5 years; 7 males) and 26 HCL adolescents (16.42 ± 1.0 years; 7 males). Subject groups were equivalent on major demographic variables (see Table S1, available online, or Results for more details). This study was approved by the Institutional Review Boards at the University of California–San Diego, the University of California–San Francisco, Rady Children's Hospital, and the County of San Diego.

Adolescents with depression were recruited from adolescent psychiatric and primary care clinics in San Diego, while healthy controls were recruited from the same geographic area via e-mail, internet, or flyers. Male and female adolescents from all ethnicities were eligible to participate. All participating adolescents provided written informed assent and their parents/legal guardian(s) provided written informed consent in accordance with the Declaration of Helsinki. All participants received financial compensation.

The Schedule for Affective Disorders and Schizophrenia for School-Age Children–Present and Lifetime Version (KSADS-PL)47 was administered to all potentially adolescents with depression. All KSADS-PL diagnoses were determined by a board certified child and adolescent psychiatrist. All MDD subjects in the study met full criteria for a primary diagnosis of MDD and were excluded if they had a primary psychiatric diagnosis other than MDD. None of our MDD subjects were diagnosed with a comorbid disruptive disorder. However, due to the high rate of comorbidity of MDD with anxiety, subjects with a past or present comorbid anxiety disorder were allowed to participate (see Table S2, available online, for a summary of the comorbidities in the MDD group). At the time of scanning, all MDD subjects were fully symptomatic and medication naïve.

The computerized Diagnostic Interview Schedule for Children 4.048 and the Diagnostic Predictive Scale49 was used to screen for the presence of any Axis I diagnoses in the HCL adolescents.

In addition to completing forms on basic demographics and general medical and developmental history, all subjects completed the following within three days of their scan session: Edinburgh Handedness Inventory50, Customary Drinking and Drug Use Record,51 Family Interview for Genetics Studies,52 Tanner Stage,53 Wechsler Abbreviated Scale of Intelligence (WASI),54 Beck Depression Inventory–II (BDI-II),55 Children's Depression Rating Scale-Revised (CDRS-R),56 Children's Global Assessment Scale (CGAS),57 and Multidimensional Anxiety Scale for Children (MASC).58 With the exception of the CDRS-R and CGAS, all other measures were self-report. One subject (HCL) failed to provide information for the MASC and was therefore not included in any statistical analyses involving this measure. Given the high proportion of participants in the study whose first language was not English, we measured IQ solely on the basis of the performance measure of the WASI.

Exclusionary criteria for the adolescents with MDD included the following:

  1. A CDRS-R t-score lower than 55

  2. Inability to fully understand and cooperate with the study procedures

  3. Having a performance IQ of less than 75

  4. Any contraindication to MR imaging (e.g., pregnancy, claustrophobia, ferrometallic implants)

  5. Any history of neurological disorders (e.g., head trauma, seizures)

  6. A learning disability

  7. Prior or present use of antidepressants

  8. Any evidence of illicit drug use, misuse of prescription drugs, or more than 2 alcohol drinks per week currently or within the previous month

  9. Pre-pubertal status (Tanner stage 1 or 2)

  10. Left-handedness

HCL adolescents were excluded from the study for any of the exclusionary criteria for the MDD group, as well as any current or lifetime Axis I psychiatric disorder, any family history of mood or psychotic disorders in first- or second-degree relatives, or a CDRS-R t-score higher than 54.

Image Acquisition

All scanning was carried out on a General Electric Discovery MR750 3T scanner (Milwaukee, WI) at the University of California–San Diego. All subjects were instructed to relax and remain awake but motionless during scanning. A fixation cross was displayed on a large screen that was viewed through a small, angled mirror; however, no eye tracking was recorded. Subjects were monitored by video and reminded before the start of the experimental session and in between each scan to remain as still as possible.

The mechanism used in standard PCASL scans to magnetically tag arterial blood is accomplished by applying a series of radiofrequency (RF) pulses and slice selective gradients.41 However, when there is a mismatch between the phase of successive RF pulses and the phase evolution of flowing spins in the blood (known as the phase tracking error), the efficiency of this tagging process can greatly deteriorate, which in turn can lead to highly inaccurate estimates of CBF.5960 Thus, we used a series of prescans to measure and minimize the phase tracking error so that the baseline ASL data could be acquired with optimal tagging efficiency and hence, a more precise measurement of CBF.39 The technical details of this PCASL method are beyond the scope of the current paper and are published elsewhere.39 The following is a brief summary of the MRI acquisition steps in sequential order (see also Figure 1): Time of flight (TOF) angiographic images were acquired (22cm field of view [FOV], 512×512 matrix, repetition time [TR]=20ms, time to echo [TE]=3.17ms, flip angle=15°, 52 1mm axial slices with an in-plane resolution of 1×1mm, scan time=1:43 min) before manually defining an optimal plane for labeling blood flowing through the feeding arteries (Figure 1A). The coordinates of the tagging plane and the feeding arteries (specifically, the right carotid artery, left carotid artery, and vertebral artery) were saved into a configuration file. The coordinates of the tagging plane were used for setting the tagging plane in all subsequent ASL scans, while the coordinates for the feeding arteries were used by the vessel-encoded ASL scan (described next) for spatial vessel encoding. The second pre-scan employed vessel-encoded ASL6163 (TR=3200ms, TE=3.17ms, flip angle=90°, tag duration=2000ms, post labeling delay=400ms, scan time=1:36min) and used the spatial coordinates of the feeding arteries to generate regional masks of the vascular territories (Figure 1B). The final pre-scans involved up to 2 multiphase PCASL (MP-PCASL; TR=3200ms, TE=3.17ms, flip angle=90°, tag duration=2000ms, post labeling delay=400ms, scan time=1:40min) scans using 8 radio frequency phase offsets to estimate the phase tracking errors in each of the arterial territory masks acquired from the previous vascular territory imaging scan (Figure 1C).5960 Note that the first MP-PCASL scan was used to measure the uncorrected phase errors while the second MP-PCASL scan was to verify that the errors were minimized after modulating the RF phase and in-plane gradients to the PCASL pulse train. If the phase tracking errors from the first MP-PCASL scan were less than 20°, then the second MP-PCASL scan was skipped, as modifications to the PCASL pulse train were not needed (Figure 1C). The optimized global RF phase and in-plane gradients determined by the MP-PCASL scan(s) were then applied to the tagging module for the PCASL scan (single-shot spiral readout, TR=4100ms, TE=3.17ms, flip angle=90°, tag duration=2000ms, post labeling delay=1600ms, 30 tagged and 30 control image pairs for 60 volumes total, scan time=4:00min). Thus, the optimized PCASL scan was a conventional PCASL scan, but with added RF phase and gradient specifications (Figure 1D). Afterward, a 36-s scan (TR=4000ms, TE=3.4ms, NEX=9, with 90° excitation pulse turned off for the first 8 repetitions) was acquired to obtain the equilibrium magnetization of cerebrospinal fluid (CSF).39 A 32-s minimum contrast scan (TR=2000ms, TE=11ms, NEX=2) using an 8-shot spiral acquisition was also acquired to estimate the combined transmit and receive coil inhomogeneities.6466 Finally, to correct for blurring in spiral images due to off-resonance fields, a B0 field map was acquired (TR=500ms, TE1=6.5ms, TE2=8.5ms, flip angle=45°, scan time=1:16min). The acquired field map was then used for offline reconstruction of all ASL data using a k-space based fast iterative image reconstruction algorithm.67 All images, except the TOF and T1-weighted data, were acquired at the same resolution: 24 cm FOV, 64×64 matrix, 20 axial slices 5mm thick with an in-plane resolution of 3.75×3.75mm.

Figure 1.

Figure 1

A graphical depiction of the prescans and pseudocontinuous arterial spin labeling (PCASL) scan in the optimized PCASL method. Note: See Image Acquisition under Method for more details). A series of time of flight (TOF) images were acquired to generate a high-resolution view of the main feeding arteries to the brain. The coordinates of the tagging plane and feeding arteries are then saved into a configuration file (Figure 1A). The spatial coordinates of the feeding arteries from the TOF scan are used to image the vascular territories via vessel-encoded arterial spin labeling (ASL) (Figure 1B). Lastly, up to 2 multiphase PCASL (MP-PCASL) scans are used to estimate phase tracking errors in each of the territory masks acquired from the vascular territorial imaging scan (Figure 1C). Note that the first MP-PCASL scan is used to measure the uncorrected phase errors while the second MP-PCASL scan is to verify that the errors are minimized after modulating the radiofrequency phase and in-plane gradients to the PCASL pulse train. If the phase tracking errors from the first MP-PCASL scan are less than 20°, then the second MP-PCASL scan is skipped (Figure 1C). The optimized global radio frequency phase and in-plane gradients determined by the MP-PCASL scan(s) are then applied to the tagging module for the PCASL scan (Figure 1D). LCA=left carotid artery; RCA=right carotid artery; VA=vertebral artery. From Shin et al. Pseudocontinuous arterial spin labeling with optimized tagging efficiency. Magnetic resonance in medicine. Oct 2012;68(4):1135-1144.39 Reprinted with permission from John Wiley and Sons.

A fast spoiled gradient recalled (FSPGR) sequence was used to collect T1-weighted images: 25.6cm FOV, 256×256 matrix, TR=8.1ms, TE=3.17ms, TI=450ms, flip angle=12°, 168 sagittal slices 1 mm thick with an in-plane resolution of 1×1mm, scan time=8:44 min.

Image Processing and Analysis

All image processing and analyses were conducted with the Analysis of Functional NeuroImages (AFNI) software,68 FMRIB Software Library (FSL),69 and Matlab (version 7.10; Natwick, MA). An in-house automated Matlab script utilizing AFNI and FSL tools was used to apply skull-stripping, motion correction, and slice-time correction to the images.39 For each participant, all ASL images were coregistered to the first volume. Next, the average running difference between the tagged and control images was computed via surround subtraction (i.e., the difference between an image and the average of its 2 nearest neighbors) to yield a perfusion-weighted time series).70 These uncorrected perfusion data in MR signal intensity units were then converted to calibrated CBF units (milliliters of blood/100 grams of tissue per minute) using an estimate of equilibrium magnetization of CSF as a reference signal from the 36-s CSF scan (see Image Acquisition above).71 The perfusion images were also corrected for transmit/receive coil inhomogeneities by dividing the time series by the minimum contrast image obtained from the 32-s minimum contrast scan (see Image Acquisition above).64 The time series was then averaged over time to yield a mean CBF value for each voxel. The anatomical images were then aligned to the CBF data and spatially normalized to Talairach72 standard space in a template provided by AFNI. The matrix derived from transforming the structural images into standard space was then applied to the CBF data, which was subsequently resampled to 4×4×4 mm resolution. Any spurious negative values in the voxels were replaced with zero.65,73 Finally, a 4.0 mm full-width half-maximum (FWHM) isotropic Gaussian filter was applied to all the voxels.65,73

Whole Brain Analysis

Regions of significant group differences (MDD versus HCL) were determined by performing a voxelwise 2-sample t-test on CBF values. Significant voxels were required to pass a voxelwise statistical threshold of t49=2.02 (p=0.05, uncorrected). To control for multiple comparisons at α=0.05, we computed the minimum number of contiguous voxels passing the voxelwise threshold that would result in a clusterwise 5% probability of being due to chance using 10,000 iterations of Monte Carlo simulations based on an average whole brain mask created from all subjects (downsampled to 4×4×4 mm). According to our simulations, the cluster threshold was 20 voxels. For group comparison, mean regional CBF (rCBF) values were extracted from each of the clusters surviving this 20 voxel threshold.

Region-of-Interest Analysis

Since limbic, paralimbic, and striatal regions have shown divergent rCBF differences in adults with depression, we defined a priori regions of interest (ROIs) targeting these areas (all bilateral): amygdala, insula, and striatum. These 3 distinct bilateral ROI masks were generated by the AFNI Talairach Daemon atlas.74 Since anatomical ROIs are often large, such that the truly active voxels make up a relatively small proportion of any anatomical ROI, we employed Monte Carlo simulations to correct for familywise error rates for each ROI mask separately.75 Such clusterwise inference methods possess more power compared to methods that adjust false positive probabilities per voxel, while still capturing the spatial nature of fMRI signals and suffering from less multiplicity than voxelwise analyses.75,76 Regions of significant group differences (MDD versus HCL) within each ROI were determined by performing a voxelwise 2-sample t-test on CBF values. To correct for the number of ROIs, a Bonferroni correction was applied at the voxelwise level, such that significant voxels were required to pass a statistical threshold of t49=2.51 (p<0.0167, corrected). Thus, the cluster threshold was determined via Monte Carlo simulations that together with the voxelwise threshold resulted in an overall 5% probability of a significant cluster surviving due to chance across all three ROIs. According to our simulations, the cluster thresholds were 3, 5, and 4 voxels for the amygdala, insula, and striatum, respectively. For group comparison, mean rCBF values were extracted from each of the clusters that survived each respective ROI's cluster threshold.

Linear Mixed Effects Model With Anxiety as a Covariate

Additionally, we ran a linear mixed effects model with rCBF as the within-subjects factor (fixed effect), group (MDD v. HCL) as the between-subjects factor, participant as the random effect, and a comorbid diagnosis of an anxiety disorder as a dichotomous covariate. Significant voxels were required to pass a voxelwise statistical threshold of F1,48=4.04 (p=0.05, uncorrected). For group comparison, mean rCBF values were extracted from each of the clusters that survived the whole brain cluster threshold of 20 voxels (see Whole Brain Analysis, above).

Sociodemographic and Clinical Scales Analysis

Statistical analyses of all demographic and clinical scales were computed with R77 and Matlab (version 7.10; Natwick, MA). Within the MDD group only, correlations between extracted mean rCBF values in the surviving clusters identified in the whole brain and ROI analyses and clinical data (i.e., BDI-II, CDRS-R, CGAS, MASC, age of onset, duration of illness, and number of depressive episodes) were examined using 2-tailed tests of Spearman's rank correlation coefficient (rs).

Results

Sociodemographic and Clinical Scales

The MDD and HCL groups did not significantly differ in age (t49=1.22, p=0.22), gender (χ21=0.007, p=0.93), ethnicity (U=338, p=0.81), Tanner stage (U=322, p=0.96), performance IQ (t49=1.20 p=0.23), or socioeconomic status (U=252.5, p=0.17). MDD adolescents showed significantly greater levels of depression as measured by BDI-II (t49=10.7, p<0.001) and CDRS-R (t49=39.6, p<0.001), significantly greater levels of anxiety as measured by MASC (t48=6.87, p<0.001), as well as significantly lower assessment of general function as measured by CGAS compared with their HCL counterparts (U=622, p<0.001). MASC scores between adolescents with and without comorbid anxiety disorders did not differ significantly (t23=0.83, p>0.05). For more details, see Table S1, available online.

Whole Brain Analysis

Twelve regions survived the analysis correcting for multiple comparisons (see Whole Brain Analysis under Method). Eight regions revealed significantly lower mean rCBF in the MDD compared to the HCL group: bilateral parahippocampual gyri/insula, right inferior frontal gyrus (IFG)/dorsolateral prefrontal cortex (DLPFC), right anterior cingulate cortex (ACC), right middle occipital gyrus, left inferior temporal gyrus, and bilateral cerebellum (see Table 1 and Figure 2). Four regions revealed significantly higher mean rCBF in the MDD compared to HCL group: right subcallosal cingulate, right putamen/lentiform nucleus (extending rostrally into the insula), and bilateral fusiform gyrus (see Table 1 and Figure 2).

Table 1. Significant Clusters From the Voxel-Based Whole Brain Analysis.

Cluster MDD rCBF (mL/100 g/min) HCL rCBF (mL/100 g/min) t-value (df=49) p-value (corrected) # of voxels x y Z
L Parahippocampal Gyrus/Insula 51.8 ± 2.7 69.7 ± 2.9 −4.51 *** 85 −40 −9 −8
R Inferior Frontal Gyrus/Dorsolateral Prefrontal (BA44/45 and BA46) 36.8 ± 2.5 57.0 ± 3.5 −4.66 *** 85 52 −29 1
R Fusiform Gyrus 57.8 ± 2.1 47.8 ± 1.8 3.63 *** 48 24 63 −6
L Cerebellum 36.8 ± 2.7 50.5 ± 2.7 −3.60 *** 47 −13 17 −19
R Anterior Cingulate Cortex 36.3 ± 2.4 50.1 ± 4.2 −2.82 *** 46 8 −22 19
L Inferior Temporal Gyrus 29.5 ± 3.1 46.3 ± 3.7 −3.50 *** 40 −52 11 −27
R Cerebellum 39.3 ± 2.2 52.8 ± 2.7 −3.86 *** 40 13 25 −19
R Parahippocampal Gyrus/Insula 50.9 ± 3.7 69.0 ± 4.0 −3.32 *** 37 35 −7 −14
L Fusiform Gyrus 70.3 ± 2.4 60.2 ± 2.1 3.17 *** 34 −15 79 −4
R Subcallosal Cingulate Gyrus 63.0 ± 5.8 44.0 ± 2.5 3.05 ** 26 17 −21 −10
R Putamen 45.3 ± 2.9 36.1 ± 1.8 2.69 * 24 27 −3 16
R Middle Occipital Gyrus 37.1 ± 1.6 46.9 ± 2.1 3.70 * 21 34 62 10

Note: See also Results and Figure 2. Extracted values for major depressive disorder (MDD) and healthy controls (HCL) reported in regional cerebral blood flow (rCBF) (mean ± standard error of mean [SEM]). Reported significance values are at the clusterwise level (see Whole Brain Analysis under Method for more details). Locations reported according to center of mass of cluster in Talairach coordinates (radiological convention). BA=Brodmann area; df=degrees of freedom; g=grams; L=left; min=minute; mL=milliliters; R=right.

*

p<0.05,

**

p< 0.01,

***

p<0.001.

Figure 2.

Figure 2

The voxel-based whole brain analysis revealed 12 clusters with significantly different regional cerebral blood flow (rCBF) levels in major depressive disorder (MDD) compared with healthy controls (HCL) (orange=increased, blue=decreased). Note: Eight clusters revealed significantly lower mean rCBF in the MDD compared to the HCL group: bilateral parahippocampal gyri/insula, right inferior frontal/dorsolateral prefrontal cortex (Brodmann area [BA] 44/45 and BA46), right anterior cingulate cortex, right middle occipital gyrus, left inferior temporal gyrus, and bilateral cerebellum. Four clusters revealed significantly higher mean rCBF in the MDD compared to HCL group: right subcallosal cingulate, right putamen, and bilateral fusiform gyrus. All locations are reported in Talairach coordinates (see Results and Table 1 for more details). Results are overlaid on a standardized Talairach template. Significance of each cluster is p<0.05 (see Whole Brain Analysis under Method for more details). L=left; R=right.

Region-of-Interest Analysis

Five regions survived the analysis correcting for multiple comparisons (see Region-of-Interest Analysis under Method). Three regions revealed significantly lower mean rCBF in the MDD compared to the HCL group: right amygdala, and bilateral inferior insula (see Table 2 and Figure 3). Two regions revealed significantly higher mean rCBF in the MDD compared to the HCL group: right superior insula (BA13) and right putamen/lentiform nucleus (see Table 2 and Figure 3).

Table 2. Significant Clusters From the Region-of-Interest (ROI) Analysis.

Cluster MDD rCBF (mL/100 g/min) HCL rCBF (mL/100 g/min) t-value (df=49) p-value (corrected) # of voxels x y z
R Insula 70.85 ± 3.14 80.10 ± 3.26 −2.04 *** 51 40 −3 1
L Insula 64.23 ± 3.18 79.93 ± 2.93 −3.64 ** 11 −44 −5 1
R Superior Insula (BA13) 69.08 ± 2.53 61.06 ± 2.94 2.06 ** 12 35 −7 13
R Putamen/Lentiform Nucleus 53.68 ± 2.29 45.99 ± 2.70 2.16 * 4 24 1 12
R Amygdala 43.12 ± 3.68 62.08 ± 5.43 −2.87 * 4 28 −2 −17

Note: See also Results and Figure 3. Extracted values for major depressive disorder (MDD) and healthy controls (HCL) reported in regional cerebral blood flow (rCBF) (mean ± standard error of mean [SEM]). Reported significance values are at the clusterwise level (see Region-of-Interest Analysis under Method for more details). Locations reported according to center of mass of cluster in Talairach coordinates (radiological convention). BA=Brodmann area; df=degrees of freedom; g=grams; L=left; min=minute; mL=milliliters; R=right;

*

p<0.05,

**

p< 0.01,

***

p<0.001.

Figure 3.

Figure 3

The region-of-interets (ROI) analysis revealed 5 clusters with significantly different regional cerebral blood flow (rCBF) levels in major depressive disorder (MDD) compared with healthy controls (HCL) (orange=increased, blue=decreased). Note: Three clusters with significantly lower rCBF levels in MDD compared with HCL: right amygdala (top row) and bilateral insula (middle row). Two clusters revealed significantly higher rCBF levels in MDD compared with HCL: right superior insula (Brodmann Area [BA] 13; middle row) and right putamen/lentiform nucleus (bottom row). All locations are reported in Talairach coordinates (see Results and Table 2 for more details). Results are overlaid on a standardized Talairach template. Significance of each cluster is p<0.05 (see Region-of-Interest Analysis under Method for more details). L=left; R=right.

Linear Mixed Effects Model With Anxiety as a Covariate

Seven regions survived the analysis correcting for multiple comparisons (see Whole Brain Analysis under Method). Six regions revealed significantly lower mean rCBF in the MDD compared to the HCL group: right inferior frontal gyrus, right anterior cingulate cortex, right cerebellum, left insula, right cingulate gyrus, and left middle temporal gyrus (see Table S3, available online). One region revealed significantly higher mean rCBF in the MDD compared to the HCL group: right putamen/lentiform nucleus (see Table S3, available online). Five of these clusters overlapped with the whole brain results (see Figure S1, available online): right IFG/DLPFC (73 overlapping voxels), right ACC (40 overlapping voxels), left insula (22 overlapping voxels), right putamen/lentiform nucleus (18 overlapping voxels), and right cerebellum (16 overlapping voxels). The directionality of perfusion differences between MDD and HCL within these clusters exactly matched the directionality of perfusion differences between MD and HCL in analogous clusters in the whole brain analysis, thereby suggesting that anxiety did not drive the differences found in our main findings.

Correlations Between rCBF and Clinical Characteristics (All Subjects With MDD)

No significant correlations were found between the clinical data and mean rCBF from the 12 clusters resulting from the whole brain analysis or the 5 clusters resulting from the ROI analysis (all p>0.05).

Correlations Between rCBF and Clinical Characteristics (Only Subjects With MDD Without Comorbidities)

Correlational analyses were also run among the MDD subjects without any comorbid diagnoses (n=12). Both mean rCBF of the left parahippocampal gyrus/insula and mean rCBF of the right IFG/DLPFC from the whole brain analysis correlated positively with age of onset (rs=0.683, p=0.02 and rs=0.619, p=0.042, respectively). Mean rCBF of the left insula from the ROI analysis correlated both positively with age of onset (rs=0.762, p=0.006;) and negatively with duration of depression (rs=−0.652, p=0.03). Finally, mean rCBF of the right inferior insula from the ROI analysis correlated negatively with the number of depressive episodes (rs=−0.724, p=0.011).

Discussion

In the present study, we employed a novel method of PCASLwith optimized tagging efficiency39 on a large cohort of nonmedicated adolescents with MDD and well-matched HCL adolescents in order to assess baseline rCBF differences between these two groups. Our study yielded 2 main results. First, we observed significant hypoperfusion in the MDD relative to the HCL group within frontal, amygdalar, insular, cingular, and cerebellar regions. Second, we found significant hyperperfusion in the MDD compared to the HCL adolescents within the subcallosal cingulate, putamen, and fusiform gyri. Importantly, these results did not qualitatively change even when we controlled for comorbid anxiety disorders in our brain analyses (see Results for more details).

In our leading hypothesis, we predicted finding rCBF differences in frontal, limbic, paralimbic, cingulate, and striatal areas. More specifically, we predicted lower rCBF in the MDD group among frontal regions. Indeed, we observed hypoperfusion in the inferior frontal gyrus and dorsolateral prefrontal cortex (see Table 1 and Figure 2) in the MDD relative to HCL adolescents. These findings mirror previous PET,59,7883 SPECT,8485 ASL3336 work showing lower baseline frontal rCBF, as well as resting state BOLD86,87 data showing altered functional connectivity in dorsolateral prefrontal cortex at both rest86 and during a cognitive task87 in adults with MDD. Hypoactivity in frontal and prefrontal areas has been strongly linked not only to psychomotor retardation,8083 but also to impaired executive functioning (e.g., attention, working memory, and decision making).8889 Together with these studies, our results suggest that reduced perfusion in these regions may be associated with some of the cognitive and motor symptoms found in adolescent MDD.

As hypothesized, we also found rCBF differences in limbic, paralimbic, and cingulate areas between MDD and HCL adolescents (see Tables 12 and Figures 23). Our finding of hypoperfusion in the anterior cingulate cortex of adolescents with MDD is consistent with several perfusion3436, 81,8485, 90–,, metabolism91, and resting state BOLD15 studies of adult depression. On the other hand, our observation of hypoperfusion in the amygdala and insula is in partial contrast with some of the prior adult perfusion33,35 showing hyperperfusion in these areas, as well as resting state BOLD studies on adult9295,15 and adolescent4296 depression failing to show altered connectivity differences. The disparity in our results may be due to differences in patient sample (e.g., age, medication status, comorbidities) or imaging technique (PCASL with optimized tagging efficiency). Nevertheless, the anterior cingulate cortex, amygdala, and insula have been shown to be involved in the processing of emotion and motivation;9732 thus, dysfunction in these structures may underlie some of the core affective symptoms seen in major depressive disorder.9294,15 It is therefore possible that our observation of hypoperfusion in these affective processing regions is a reflection of reduced motivation or feelings of anhedonia that are commonly present in adolescent depression.

Consistent with our second hypothesis, we also found significant hyperperfusion in the MDD relative to HCL group in the right subcallosal cingulate and right superior insula (see Tables 12 and Figures 23). Our results in the subcallosal cingulate are substantiated by the current literature of adults with depression exhibiting hyperperfusion in this region during baseline,7 ,32 as well as our previously published neuroimaging work on greater task-evoked activation in this region among adolescents with depression.100 Given its anatomical connections to frontal, limbic, and paralimbic structures,101 the subcallosal cingulate is thought to lie at the interface of cognitive and affective processing, such that aberrant functioning in this region leads to impaired emotion regulation.7,28 Indeed, several perfusion studies in adult MDD have demonstrated elevated baseline rCBF in the subcallosal cingulate during depressive relapse102103 that decreases with remission,104 effective antidepressant treatment,105106 electroconvulsive therapy,107 and deep brain stimulation.29, 108,109 Reduced glucose metabolism in the insula has also been shown to correlate with symptom improvement among adults with treatment-resistant MDD,30 while increased insular activation has been reported in both healthy adults110112 and adults with depression113 while experiencing exceptionally negative emotions. Similarly, BOLD rsfMRI studies in both young adults17,21 and adolescents2123 have shown altered functional connectivity in affective networks based within the subcallosal cingular area, particularly between paralimbic and limbic sites, including the insula, amygdala, and striatal structures. One possible interpretation of our results is that atypical hyperactivity in the subcallosal cingulate and superior insula leads to overreaction to and improper emotional regulation of negative stimuli during adolescent depression. However, more studies are needed to investigate how both hypo- and hyperperfusion within distinct parts of the insula relate to both adolescent and adult MDD.

Abnormally increased metabolism in the putamen and fusiform gyri in adult depression has been less frequently described.35,114 ,115 However, some evidence for the role of these regions in affective processing in adult depression exists, including the involvement of the putamen in the processing of negatively valenced stimuli112 and an observed increase in putaminal rCBF during acute depression34 that decreases with remission.102 More recently, one resting state BOLD study reported weaker functional connectivity between the ventral putamen and ventromedial prefrontal cortex in adults with MDD.16 Task-based fMRI studies have also documented increased activation in the putamen in adult healthy controls,115117 as well as increased activation in the fusiform gyrus in adults with depression113 and control115117 adults during viewing emotional stimuli. Similar to the current study, increased rCBF has also been observed in the fusiform gyrus of adults with depression at rest114. These results suggest that future work should investigate whether the putamen and fusiform are critical to adverse responses to negative stimuli in adolescents with depression and whether these regions are functionally connected to other structures involved in affective processing.118

Lastly, our observation of cerebellar hypoperfusion in adolescents with MDD is consistent with emerging evidence that the cerebellum influences not only motor function, but also affective processing via connections to limbic structures.119123 Cerebellar lesions in both adults124 and children125 lead to psychomotor retardation, passivity, and a blunting of emotion that is behaviorally similar to depression and other mood disorders. PET data in adults with depression have also shown decreased cerebellar rCBF and lower brain activation at baseline.126 Likewise, resting state BOLD fMRI127130 has demonstrated altered cerebellar functional connectivity with parts of prefrontal cortex,127130 cingulate cortex,129,130 temporal poles,129,130 and the fusiform gyrus.128,130 While more studies are needed to clarify the role of the cerebellum in major depression and mood disorders, our current results suggest that there are significant cerebellar differences between adolescents with MDD and healthy controls.

Along with several other perfusion studies on adult depression,3336,131 we did not find any significant correlations between mean rCBF and clinical data among our MDD group. When omitting MDD subjects with a comorbid anxiety disorder from our correlational analyses, however, we did find some significant associations between mean rCBF and clinical characteristics (see Results for more details). Although these results do seem to suggest that our study and prior studies3336,131may not have found predictive relationships between mean rCBF and clinical data due to the homogeneity of MDD patients recruited, given the low number of subjects (n=12) and the total number of correlation tests run (7) performed for this analysis, these results must be viewed with caution.

Our results must nevertheless be interpreted in light of the study's limitations. As the present study is cross-sectional, we cannot address whether these perfusion patterns precede or are a product of adolescent depression. Future longitudinal studies are therefore needed to examine cerebral blood flow levels prior to the onset of adolescent depression and how they may normalize with recovery. Task-based studies could also be carried out in order to assess how perfusion patterns among these executive, affective, and motor networks differ between adolescents with depression and healthy controls when faced with emotional stimuli and/or cognitive tasks and to assess to what degree, if any, these perfusion patterns change. Correlating changes in regional CBF with performance on cognitive testing (particularly in the domains of memory, affect, and psychomotor function) outside of the scanner may also further elucidate how differences in these brain networks may be related to the clinical symptoms of adolescents with MDD. Functional connectivity analyses with perfusion data would also be immensely useful in ascertaining the distributed brain network that is affected by adolescent depression. Furthermore, longitudinal studies could assess how the strength of these network connections change in terms of blood flow during the progression of MDD. It should be noted that the optimized PCASL scan sequence presented in this paper was not long enough (4 minutes) for us to perform a functional connectivity analysis or examine time effects (beginning versus end of scan), as more acquisitions would have been needed to ensure adequate signal-to-noise ratio (SNR). In comparison to BOLD resting state fMRI, ASL perfusion imaging tends to yield lower SNR and necessitates a pair of volumes (tagged v. control) to produce a single CBF-weighted volume, hence requiring longer scan times.132,133 Despite these methodological limitations, the optimized tagging efficiency of our PCASL method yields high quality CBF images and establishes the use of a novel ASL-based method to noninvasively study perfusion in adolescent depression. Future studies could test our novel optimized PCASL method with a longer scan sequence in order to investigate functional connectivity differences between adolescents with depression and healthy adolescents (see Chuang et al., 2008,134 Viviani et al., 2011,133 and Liu et al., 2013135 for recent examples of functional connectivity analyses on pulsed and continuous ASL perfusion data using much longer scan times in adults). Finally, the absence of a comparator morbid group (e.g., anxiety disorders) in the present study restricts how much our findings can be generalized to adolescents with depression without comorbidities. While our voxel-based analyses controlling for comorbid anxiety suggest that anxiety did not contribute significantly to our brain results, future studies must nevertheless include comparator morbid groups to validate and replicate our observations.

The clinical implications of our findings suggest that patterns of baseline regional CBF within the fronto-limbic-cingulate-striatal-cerebellar network may be a candidate biomarker for adolescent MDD. Determining whether and how divergence of these rCBF patterns from that typical of healthy adolescents relates to depressive severity and other clinical characteristics of adolescent MDD could potentially assist in the early diagnosis, intervention, and potential prevention of this disorder. Additionally, since several antidepressants affect blood flow,37,38 rCBF could also be utilized to help determine potential therapeutic targets for treatment and to assess pharmacological effects.105,106,136 Nevertheless, more research is needed to specifically link identifying patterns of perfusion with the clinical symptoms and behaviors that characterize adolescent MDD.

Our results establish the use of advanced ASL methods as a highly effective noninvasive neuroimaging tool for measuring baseline CBF in both adolescents with depression and healthy adolescents. Compared to techniques such as PET or SPECT, ASL enjoys the practical advantages of being noninvasive, is relatively straightforward to implement, and allows for repeated scanning safely within a single subject without the use of radioisotopes. BOLD fMRI is also noninvasive, but offers information that is subtly distinct from ASL: functional connectivity analyses of BOLD resting state data can be used to identify intrinsic networks in the brain, while ASL is able to show the base utilization of these individual network components (i.e., brain regions) by measuring actual blood flow. Interestingly, at least one study has shown no correlation between functional connectivity and mean perfusion levels, suggesting that both of these aspects of the resting state could potentially represent different brain markers.133 However, the BOLD signal is not an absolute measure of brain function and is sensitive to vascular factors such as blood flow. Thus, the estimate of an absolute neurophysiological brain measure from ASL offers great promise as a noninvasive technique for detecting subtle changes in brain function for the purposes of diagnosis and treatment assessment in clinical research studies, particularly when used in conjunction with BOLD fMRI techniques.13,137 Relative to other ASL methods, PCASL has a higher test–retest reliability,138 higher intrasubject SNR,40 and lower intersubject variability139 and consequently, has become progressively more popular among researchers wishing to noninvasively measure cerebral blood flow.11,109 Thus, as PCASL methods become more refined and widely available, their potential for clinical utility will continue to grow.

In conclusion, we used a novel method of pseudocontinuous arterial spin labeling that optimizes tagging efficiency and found abnormal hypoperfusion in executive, affective, and motor networks of the brain and abnormal hyperperfusion in areas supporting emotional regulation in a relatively large sample of medication-naïve adolescents with depression compared to a group of well-matched healthy controls. Combined with prior neuroimaging work on depression, our results suggest that dysfunction in these networks may contribute to the cognitive, affective, and psychomotor symptoms commonly present in adolescent depression. Finally, our study demonstrates the efficacy of pseudocontinuous arterial spin labeling in understanding adolescent major depressive disorder and advances the possibility of using such arterial spin labeling methods for clinical purposes in the future.

Supplementary Material

01

Figure S1. Overlap between whole brain results and linear mixed effects modeling results. Note: The linear mixed effects model (see “Linear mixed effects model with anxiety as a covariate” under Method in main text) controlling for anxiety revealed 7 clusters with significantly different regional cerebral blood flow (rCBF) levels in major depressive disorder (MDD) compared with healthy controls (HCL) (see Table S3, available online). Five of these clusters overlapped with the whole brain results: right inferior frontal/dorsolateral prefrontal cortex (73 overlapping voxels), right anterior cingulate cortex (40 overlapping voxels), left insula (22 overlapping voxels), right putamen/lentiform nucleus (18 overlapping voxels), and right cerebellum (16 overlapping voxels), thereby suggesting that anxiety did not drive the differences found in our main findings. BA=Brodmann area; L=left; R=right.

Acknowledgments

This work was supported by the National Institute of Mental Health (NIMH; R01MH085734 and R01MH085734-02S1) and the National Alliance for Research on Schizophrenia and Depression (NARSAD) Foundation (T.T.Y.). Arterial spin labeling (ASL) data upload, postprocessing, and data storage were graciously provided by the Cerebral Blood Flow Biomedical Informatics Research Network (CBFBIRN) project (http://cbfbirn.ucsd.edu; R01MH084796 to T.T.L.).

Dr. Simmons served as the statistical expert for this research.

The authors thank Napoleon Hoang, H.S., and Melanie Chan, B.S., of the University of California–San Diego, for their invaluable help in data collection and Alison Yaeger, Psy.D., of the University of California–San Francisco for helpful comments.

Footnotes

Supplemental material cited in this article is available online.

Disclosure: Dr. Liu has received grant or research support from GE Medical Systems. Dr. Tapert has received grant or research support from the National Institutes of Health (NIH) and Veterans Affairs. Dr. Frank has received grant or research support from NIH and has served as a consultant to the Eating Disorder Center of Denver. Dr. Max has received grant or research support from NIH and has provided expert testimony in cases of traumatic brain injury on an ad hoc basis for plaintiffs and defendants on a more or less equal ratio. Dr. Wolkowitz has received grant or research support from NIH and the Department of Defense, and has served on the scientific advisory board for Telome Health, Inc. Dr. Eisendrath has received grant or research support from NIH and the Mellam Foundation. Dr. Hoeft has received grant or research support from NIH. Dr. Hood has received grant or research support from NIH. Dr. Hendren has received grant or research support from Forest Pharmaceuticals, Inc., Curemark, BioMarin Pharmaceutical, Roche, Autism Speaks, the Vitamin D Council, and NIMH. He has also served on the advisory boards for Biomarin, Forest, and Janssen. Dr. Paulus has received grant or research support from NIH. Dr. Simmons has received grant or research support from Veterans Affairs and NIH. Drs. Ho, Shin, Connolly, and Yang, Mr. Wu, Mr. Yang, and Mr. Banerjee report no biomedical financial interests or potential conflicts of interest.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Contributor Information

Dr. Tiffany C. Ho, The University of California, San Francisco

Dr., Mr. Jing Wu, The University of California, San Francisco, The University of Colorado, Denver and Health Sciences Center

Dr. David D. Shin, The University of California, San Diego; The Center of Functional Magnetic Resonance Imaging

Dr. Thomas T. Liu, The University of California, San Diego; The Center of Functional Magnetic Resonance Imaging

Dr. Susan F. Tapert, The University of California, San Diego; Psychiatry Service, Veterans Affairs San Diego Health Care System

Dr., Mr. Guang Yang, The University of California, San Francisco; The University of California, San Diego

Dr. Colm G. Connolly, The University of California, San Francisco

Dr. Guido K.W. Frank, The University of Colorado, Denver and Health Sciences Center

Dr. Jeffrey E. Max, The University of California, San Diego; Rady Children's Hospital

Dr. Owen Wolkowitz, The University of California, San Francisco

Dr. Stuart Eisendrath, The University of California, San Francisco

Dr. Fumiko Hoeft, The University of California, San Francisco

Mr. Dipavo Banerjee, The University of California, San Diego

Dr. Korey Hood, The University of California, San Francisco

Dr. Robert L. Hendren, The University of California, San Francisco

Dr. Martin P. Paulus, The University of California, San Diego

Dr. Alan N. Simmons, The University of California, San Diego; Psychiatry Service, Veterans Affairs San Diego Health Care System

Dr. Tony T. Yang, The University of California, San Francisco; The University of California, San Diego

References

  • 1.The World Health Organization. The global burden of disease: 2004 update, Table 9: Estimated prevalence of moderate and severe disability for leading disabling conditions by age, for high-income and low- and middle-income countries, 2004. 2008 http://www.who.int/healthinfo/global_burden_disease/GBD_report2004update_full.pdf.
  • 2.Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA : the journal of the American Medical Association. 2003 Jun 18;289(23):3095–3105. doi: 10.1001/jama.289.23.3095. [DOI] [PubMed] [Google Scholar]
  • 3.Kessler RC, Angermeyer M, Anthony JC, et al. Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization's World Mental Health Survey Initiative. World psychiatry : official journal of the World Psychiatric Association (WPA) 2007 Oct;6(3):168–176. [PMC free article] [PubMed] [Google Scholar]
  • 4.Pine DS, Cohen E, Cohen P, Brook J. Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder? The American journal of psychiatry. 1999 Jan;156(1):133–135. doi: 10.1176/ajp.156.1.133. [DOI] [PubMed] [Google Scholar]
  • 5.Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K. Depression: perspectives from affective neuroscience. Annual review of psychology. 2002;53:545–574. doi: 10.1146/annurev.psych.53.100901.135148. [DOI] [PubMed] [Google Scholar]
  • 6.Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. British medical bulletin. 2003;65:193–207. doi: 10.1093/bmb/65.1.193. [DOI] [PubMed] [Google Scholar]
  • 7.Seminowicz DA, Mayberg HS, McIntosh AR, et al. Limbic-frontal circuitry in major depression: a path modeling metanalysis. NeuroImage. 2004 May;22(1):409–418. doi: 10.1016/j.neuroimage.2004.01.015. [DOI] [PubMed] [Google Scholar]
  • 8.Videbech P. PET measurements of brain glucose metabolism and blood flow in major depressive disorder: a critical review. Acta psychiatrica Scandinavica. 2000 Jan;101(1):11–20. doi: 10.1034/j.1600-0447.2000.101001011.x. [DOI] [PubMed] [Google Scholar]
  • 9.Smith DJ, Cavanagh JT. The use of single photon emission computed tomography in depressive disorders. Nuclear medicine communications. 2005 Mar;26(3):197–203. doi: 10.1097/00006231-200503000-00004. [DOI] [PubMed] [Google Scholar]
  • 10.Detre JA, Wang J. Technical aspects and utility of fMRI using BOLD and ASL. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. 2002 May;113(5):621–634. doi: 10.1016/s1388-2457(02)00038-x. [DOI] [PubMed] [Google Scholar]
  • 11.Detre JA, Wang J, Wang Z, Rao H. Arterial spin-labeled perfusion MRI in basic and clinical neuroscience. Current opinion in neurology. 2009 Aug;22(4):348–355. doi: 10.1097/WCO.0b013e32832d9505. [DOI] [PubMed] [Google Scholar]
  • 12.Greicius M. Resting-state functional connectivity in neuropsychiatric disorders. Current opinion in neurology. 2008 Aug;21(4):424–430. doi: 10.1097/WCO.0b013e328306f2c5. [DOI] [PubMed] [Google Scholar]
  • 13.Brown GGC C, Liu TT. Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications. J Int Psychol Soc. 2007;23:526–538. doi: 10.1017/S1355617707070634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nature reviews Neuroscience. 2007 Sep;8(9):700–711. doi: 10.1038/nrn2201. [DOI] [PubMed] [Google Scholar]
  • 15.Anand A, Li Y, Wang Y, Lowe MJ, Dzemidzic M. Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression. Psychiatry research. 2009 Mar 31;171(3):189–198. doi: 10.1016/j.pscychresns.2008.03.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Furman DJ, Hamilton JP, Gotlib IH. Frontostriatal functional connectivity in major depressive disorder. Biology of mood and anxiety disorders. 2011;1(1):11. doi: 10.1186/2045-5380-1-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Greicius MD, Flores BH, Menon V, et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biological psychiatry. 2007 Sep 1;62(5):429–437. doi: 10.1016/j.biopsych.2006.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hamilton JP, Chen G, Thomason ME, Schwartz ME, Gotlib IH. Investigating neural primacy in Major Depressive Disorder: multivariate Granger causality analysis of resting-state fMRI time-series data. Molecular psychiatry. 2011 Jul;16(7):763–772. doi: 10.1038/mp.2010.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Sheline YI, Price JL, Yan Z, Mintun MA. Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexus; Proceedings of the National Academy of Sciences of the United States of America; Jun 15 2010; pp. 11020–11025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Veer IM, Beckmann CF, van Tol MJ, et al. Whole brain resting-state analysis reveals decreased functional connectivity in major depression. Frontiers in systems neuroscience. 2010;4 doi: 10.3389/fnsys.2010.00041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Davey CG, Harrison BJ, Yucel M, Allen NB. Regionally specific alterations in functional connectivity of the anterior cingulate cortex in major depressive disorder. Psychological medicine. 2012 Oct;42(10):2071–2081. doi: 10.1017/S0033291712000323. [DOI] [PubMed] [Google Scholar]
  • 22.Connolly C, W J, Ho TC, Hoeft F, Wolkowitz O, Eisendrath S, Frank G, Hendren R, Max JE, Paulus MP, Tapert SF, Banerjee D, Simmons AN, Yang TT. Resting state functional connectivity of subgenual anterior cingulate cortex in adolescents with depression. Biological psychiatry. doi: 10.1016/j.biopsych.2013.05.036. under review. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Cullen KR, Gee DG, Klimes-Dougan B, et al. A preliminary study of functional connectivity in comorbid adolescent depression. Neuroscience letters. 2009 Sep 4;460(3):227–231. doi: 10.1016/j.neulet.2009.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Liu Z, Xu C, Xu Y, et al. Decreased regional homogeneity in insula and cerebellum: a resting-state fMRI study in patients with major depression and subjects at high risk for major depression. Psychiatry research. 2010 Jun 30;182(3):211–215. doi: 10.1016/j.pscychresns.2010.03.004. [DOI] [PubMed] [Google Scholar]
  • 25.Bokkers RP, Bremmer JP, van Berckel BN, et al. Arterial spin labeling perfusion MRI at multiple delay times: a correlative study with H(2)(15)O positron emission tomography in patients with symptomatic carotid artery occlusion. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2010 Jan;30(1):222–229. doi: 10.1038/jcbfm.2009.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Borogovac A, Asllani I. Arterial Spin Labeling (ASL) fMRI: advantages, theoretical constrains, and experimental challenges in neurosciences. International journal of biomedical imaging. 2012;2012:818456. doi: 10.1155/2012/818456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bonne O, Krausz Y. Pathophysiological significance of cerebral perfusion abnormalities in major depression-trait or state marker? European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 1997 Aug;7(3):225–233. doi: 10.1016/s0924-977x(97)00410-0. [DOI] [PubMed] [Google Scholar]
  • 28.Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. The Journal of neuropsychiatry and clinical neurosciences. 1997 Summer;9(3):471–481. doi: 10.1176/jnp.9.3.471. [DOI] [PubMed] [Google Scholar]
  • 29.Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005 Mar 3;45(5):651–660. doi: 10.1016/j.neuron.2005.02.014. [DOI] [PubMed] [Google Scholar]
  • 30.Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological psychiatry. 2008 Sep 15;64(6):461–467. doi: 10.1016/j.biopsych.2008.05.034. [DOI] [PubMed] [Google Scholar]
  • 31.Holtzheimer PE, 3rd, Mayberg HS. Deep brain stimulation for treatment-resistant depression. The American journal of psychiatry. 2010 Dec;167(12):1437–1444. doi: 10.1176/appi.ajp.2010.10010141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Pizzagalli DA. Frontocingulate dysfunction in depression: toward biomarkers of treatment response. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2011 Jan;36(1):183–206. doi: 10.1038/npp.2010.166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Clark CP, Brown GG, Archibald SL, et al. Does amygdalar perfusion correlate with antidepressant response to partial sleep deprivation in major depression? Psychiatry research. 2006 Jan 30;146(1):43–51. doi: 10.1016/j.pscychresns.2005.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Lui S, Parkes LM, Huang X, et al. Depressive disorders: focally altered cerebral perfusion measured with arterial spin-labeling MR imaging. Radiology. 2009 May;251(2):476–484. doi: 10.1148/radiol.2512081548. [DOI] [PubMed] [Google Scholar]
  • 35.Duhameau B, Ferre JC, Jannin P, et al. Chronic and treatment-resistant depression: a study using arterial spin labeling perfusion MRI at 3Tesla. Psychiatry research. 2010 May 30;182(2):111–116. doi: 10.1016/j.pscychresns.2010.01.009. [DOI] [PubMed] [Google Scholar]
  • 36.Jarnum H, Eskildsen SF, Steffensen EG, et al. Longitudinal MRI study of cortical thickness, perfusion, and metabolite levels in major depressive disorder. Acta psychiatrica Scandinavica. 2011 Dec;124(6):435–446. doi: 10.1111/j.1600-0447.2011.01766.x. [DOI] [PubMed] [Google Scholar]
  • 37.Viviani R, Abler B, Seeringer A, Stingl JC. Effect of paroxetine and bupropion on human resting brain perfusion: an arterial spin labeling study. NeuroImage. 2012 Jul 16;61(4):773–779. doi: 10.1016/j.neuroimage.2012.03.014. [DOI] [PubMed] [Google Scholar]
  • 38.Noskin O, Jafarimojarrad E, Libman RB, Nelson JL. Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants. Neurology. 2006 Jul 11;67(1):159–160. doi: 10.1212/01.wnl.0000223648.76430.27. [DOI] [PubMed] [Google Scholar]
  • 39.Shin DD, Liu TT, Wong EC, Shankaranarayanan A, Jung Y. Pseudocontinuous arterial spin labeling with optimized tagging efficiency. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2012 Oct;68(4):1135–1144. doi: 10.1002/mrm.24113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Wu WC, Fernandez-Seara M, Detre JA, Wehrli FW, Wang J. A theoretical and experimental investigation of the tagging efficiency of pseudocontinuous arterial spin labeling. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2007 Nov;58(5):1020–1027. doi: 10.1002/mrm.21403. [DOI] [PubMed] [Google Scholar]
  • 41.Dai W, Garcia D, de Bazelaire C, Alsop DC. Continuous flow-driven inversion for arterial spin labeling using pulsed radio frequency and gradient fields. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2008 Dec;60(6):1488–1497. doi: 10.1002/mrm.21790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Yang TT, Simmons AN, Matthews SC, et al. Adolescents with major depression demonstrate increased amygdala activation. Journal of the American Academy of Child and Adolescent Psychiatry. 2010 Jan;49(1):42–51. doi: 10.1097/00004583-201001000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Sliz D, Hayley S. Major depressive disorder and alterations in insular cortical activity: a review of current functional magnetic imaging research. Frontiers in human neuroscience. 2012;6:323. doi: 10.3389/fnhum.2012.00323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Forbes EE, Hariri AR, Martin SL, et al. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. The American journal of psychiatry. 2009 Jan;166(1):64–73. doi: 10.1176/appi.ajp.2008.07081336. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Forbes EE. fMRI studies of reward processing in adolescent depression. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2011 Jan;36(1):372–373. doi: 10.1038/npp.2010.164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kaufman J, Martin A, King RA, Charney D. Are child-, adolescent-, and adult-onset depression one and the same disorder? Biological psychiatry. 2001 Jun 15;49(12):980–1001. doi: 10.1016/s0006-3223(01)01127-1. [DOI] [PubMed] [Google Scholar]
  • 47.Kaufman J, Birmaher B, Brent DA, Ryan ND, Rao U. K-SADS-PL. Journal of the American Academy of Child and Adolescent Psychiatry. 2000 Oct;39(10):1208. doi: 10.1097/00004583-200010000-00002. [DOI] [PubMed] [Google Scholar]
  • 48.Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry. 2000 Jan;39(1):28–38. doi: 10.1097/00004583-200001000-00014. [DOI] [PubMed] [Google Scholar]
  • 49.Lucas CP, Zhang H, Fisher PW, et al. The DISC Predictive Scales (DPS): efficiently screening for diagnoses. Journal of the American Academy of Child and Adolescent Psychiatry. 2001 Apr;40(4):443–449. doi: 10.1097/00004583-200104000-00013. [DOI] [PubMed] [Google Scholar]
  • 50.Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971 Mar;9(1):97–113. doi: 10.1016/0028-3932(71)90067-4. [DOI] [PubMed] [Google Scholar]
  • 51.Brown SA, Myers MG, Lippke L, Tapert SF, Stewart DG, Vik PW. Psychometric evaluation of the Customary Drinking and Drug Use Record (CDDR): a measure of adolescent alcohol and drug involvement. Journal of studies on alcohol. 1998 Jul;59(4):427–438. doi: 10.15288/jsa.1998.59.427. [DOI] [PubMed] [Google Scholar]
  • 52.Maxwell ME. Family Interview for Genetic Studies (FIGS): A manual for FIGS. Rockville, MD: National Institute of Mental Health; 1992. [Google Scholar]
  • 53.Tanner J. Growth and Adolescence. Oxford: Blackwell; 1962. [Google Scholar]
  • 54.Wechsler D. Wechsler Abbreviated Scale of Intelligence Administration and Scoring Manual. San Antonio, TX: The Psychological Corporation; 1999. [Google Scholar]
  • 55.Beck AT, Steer RA, Brown GK. Beck Depression Inventory-Second Edition Manual. San Antonio, TX: The Psychological Corporation; 1996. [Google Scholar]
  • 56.Poznanski EO. Children's Depressing Rating Scale-Revised (CDRS-R) Western Psychological Services; 1996. [Google Scholar]
  • 57.Shaffer D, Gould MS, Brasic J, et al. A children's global assessment scale (CGAS) Archives of general psychiatry. 1983 Nov;40(11):1228–1231. doi: 10.1001/archpsyc.1983.01790100074010. [DOI] [PubMed] [Google Scholar]
  • 58.March JS, Parker JD, Sullivan K, Stallings P, Conners CK. The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity. Journal of the American Academy of Child and Adolescent Psychiatry. 1997 Apr;36(4):554–565. doi: 10.1097/00004583-199704000-00019. [DOI] [PubMed] [Google Scholar]
  • 59.Jung Y, Wong EC, Liu TT. Multiphase pseudocontinuous arterial spin labeling (MP-PCASL) for robust quantification of cerebral blood flow. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2010 Sep;64(3):799–810. doi: 10.1002/mrm.22465. [DOI] [PubMed] [Google Scholar]
  • 60.Jung Y, Liu TT. ISMRM. Stockhold, Sweden: 2010. Fast CBF estimation in multi-phase pseudo-continuous arterial spin labeling (MP-PCASL) using signal demodulation. [Google Scholar]
  • 61.Wong EC. Vessel-encoded arterial spin-labeling using pseudocontinuous tagging. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2007 Dec;58(6):1086–1091. doi: 10.1002/mrm.21293. [DOI] [PubMed] [Google Scholar]
  • 62.Kansagra AP, Wong EC. Mapping of vertebral artery perfusion territories using arterial spin labeling MRI. Journal of magnetic resonance imaging : JMRI. 2008 Sep;28(3):762–766. doi: 10.1002/jmri.21462. [DOI] [PubMed] [Google Scholar]
  • 63.Wong E, Kansagra A. ISMRM. Toronto, Cananda: 2008. Mapping middle cerebral artery branch territories with vessel encoded pseudocontinuous ASL: Sine/Cosine tag modulation and data clustering in tagging efficiency space. [Google Scholar]
  • 64.Brumm KP, Perthen JE, Liu TT, Haist F, Ayalon L, Love T. An arterial spin labeling investigation of cerebral blood flow deficits in chronic stroke survivors. NeuroImage. 2010 Jul 1;51(3):995–1005. doi: 10.1016/j.neuroimage.2010.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Wierenga CE, Dev SI, Shin DD, et al. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2012 Aug;32(8):1589–1599. doi: 10.1038/jcbfm.2012.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Wang J, Qiu M, Constable RT. In vivo method for correcting transmit/receive nonuniformities with phased array coils. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 2005 Mar;53(3):666–674. doi: 10.1002/mrm.20377. [DOI] [PubMed] [Google Scholar]
  • 67.Noll DC, Fessler JA, Sutton BP. Conjugate phase MRI reconstruction with spatially variant sample density correction. IEEE transactions on medical imaging. 2005 Mar;24(3):325–336. doi: 10.1109/tmi.2004.842452. [DOI] [PubMed] [Google Scholar]
  • 68.Cox RW. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Computers and biomedical research, an international journal. 1996 Jun;29(3):162–173. doi: 10.1006/cbmr.1996.0014. [DOI] [PubMed] [Google Scholar]
  • 69.Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage. 2004;23(1):S208–219. doi: 10.1016/j.neuroimage.2004.07.051. [DOI] [PubMed] [Google Scholar]
  • 70.Liu TT, Wong EC. A signal processing model for arterial spin labeling functional MRI. NeuroImage. 2005 Jan 1;24(1):207–215. doi: 10.1016/j.neuroimage.2004.09.047. [DOI] [PubMed] [Google Scholar]
  • 71.Chalela JA, Alsop DC, Gonzalez-Atavales JB, Maldjian JA, Kasner SE, Detre JA. Magnetic resonance perfusion imaging in acute ischemic stroke using continuous arterial spin labeling. Stroke; a journal of cerebral circulation. 2000 Mar;31(3):680–687. doi: 10.1161/01.str.31.3.680. [DOI] [PubMed] [Google Scholar]
  • 72.Talairach J, Tournoux P. Co-planar Stereotaxis Atlas of the Human Brain. New York: Theime; 1998. Three-Dimensional Proportional System: An Approach to Cerebral Imaging. [Google Scholar]
  • 73.Brown GG, Eyler Zorrilla LT, Georgy B, Kindermann SS, Wong EC, Buxton RB. BOLD and perfusion response to finger-thumb apposition after acetazolamide administration: differential relationship to global perfusion. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2003 Jul;23(7):829–837. doi: 10.1097/01.WCB.0000071887.63724.B2. [DOI] [PubMed] [Google Scholar]
  • 74.Lancaster JL, Woldorff MG, Parsons LM, et al. Automated Talairach atlas labels for functional brain mapping. Human brain mapping. 2000 Jul;10(3):120–131. doi: 10.1002/1097-0193(200007)10:3&#x0003c;120::AID-HBM30&#x0003e;3.0.CO;2-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 1995 May;33(5):636–647. doi: 10.1002/mrm.1910330508. [DOI] [PubMed] [Google Scholar]
  • 76.Nichols TE. Multiple testing corrections, nonparametric methods, and random field theory. NeuroImage. 2012 Aug 15;62(2):811–815. doi: 10.1016/j.neuroimage.2012.04.014. [DOI] [PubMed] [Google Scholar]
  • 77.R Development Core Team. A Language and Environment for Statistical Computing. (2nd) 2012 http://cran.r-project.org/docs/manuals/fullrefman.pdf.
  • 78.Rogers MA, Bradshaw JL, Pantelis C, Phillips JG. Frontostriatal deficits in unipolar major depression. Brain research bulletin. 1998 Nov 1;47(4):297–310. doi: 10.1016/s0361-9230(98)00126-9. [DOI] [PubMed] [Google Scholar]
  • 79.Dolan RJ, Bench CJ, Liddle PF, et al. Dorsolateral prefrontal cortex dysfunction in the major psychoses; symptom or disease specificity? Journal of neurology, neurosurgery, and psychiatry. 1993 Dec;56(12):1290–1294. doi: 10.1136/jnnp.56.12.1290. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Galynker, Cai J, Ongseng F, Finestone H, Dutta E, Serseni D. Hypofrontality and negative symptoms in major depressive disorder. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1998 Apr;39(4):608–612. [PubMed] [Google Scholar]
  • 81.Baxter LR, Jr, Phelps ME, Mazziotta JC, et al. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Archives of general psychiatry. 1985 May;42(5):441–447. doi: 10.1001/archpsyc.1985.01790280019002. [DOI] [PubMed] [Google Scholar]
  • 82.Martinot JL, Hardy P, Feline A, et al. Left prefrontal glucose hypometabolism in the depressed state: a confirmation. The American journal of psychiatry. 1990 Oct;147(10):1313–1317. doi: 10.1176/ajp.147.10.1313. [DOI] [PubMed] [Google Scholar]
  • 83.Bench CJ, Friston KJ, Brown RG, Scott LC, Frackowiak RS, Dolan RJ. The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression. Psychological medicine. 1992 Aug;22(3):607–615. doi: 10.1017/s003329170003806x. [DOI] [PubMed] [Google Scholar]
  • 84.Pagani M, Gardner A, Salmaso D, et al. Principal component and volume of interest analyses in depressed patients imaged by 99mTc-HMPAO SPET: a methodological comparison. European journal of nuclear medicine and molecular imaging. 2004 Jul;31(7):995–1004. doi: 10.1007/s00259-004-1457-5. [DOI] [PubMed] [Google Scholar]
  • 85.Lee WH, Chung YA, Seo YY, et al. Alterations of regional cerebral blood flow in major depressive disorder. Nuclear Medicine and Molecular Imaging. 2009 Apr;43(2):107–111. [Google Scholar]
  • 86.Ye T, Peng J, Nie B, et al. Altered functional connectivity of the dorsolateral prefrontal cortex in first-episode patients with major depressive disorder. European journal of radiology. 2012 Dec;81(12):4035–4040. doi: 10.1016/j.ejrad.2011.04.058. [DOI] [PubMed] [Google Scholar]
  • 87.Vasic N, Walter H, Sambataro F, Wolf RC. Aberrant functional connectivity of dorsolateral prefrontal and cingulate networks in patients with major depression during working memory processing. Psychological medicine. 2009 Jun;39(6):977–987. doi: 10.1017/S0033291708004443. [DOI] [PubMed] [Google Scholar]
  • 88.Paelecke-Habermann Y, Pohl J, Leplow B. Attention and executive functions in remitted major depression patients. Journal of affective disorders. 2005 Dec;89(1-3):125–135. doi: 10.1016/j.jad.2005.09.006. [DOI] [PubMed] [Google Scholar]
  • 89.Fossati P, Ergis AM, Allilaire JF. Executive functioning in unipolar depression: a review. L'Encephale. 2002 Mar-Apr;28(2):97–107. [PubMed] [Google Scholar]
  • 90.Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport. 1997 Mar 3;8(4):1057–1061. doi: 10.1097/00001756-199703030-00048. [DOI] [PubMed] [Google Scholar]
  • 91.Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biological psychiatry. 2000 Feb 15;47(4):305–313. doi: 10.1016/s0006-3223(99)00159-6. [DOI] [PubMed] [Google Scholar]
  • 92.Drevets WC. Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Current opinion in neurobiology. 2001 Apr;11(2):240–249. doi: 10.1016/s0959-4388(00)00203-8. [DOI] [PubMed] [Google Scholar]
  • 93.Drevets WC, Price JL, Simpson JR, Jr, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. 1997 Apr 24;386(6627):824–827. doi: 10.1038/386824a0. [DOI] [PubMed] [Google Scholar]
  • 94.Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Annals of the New York Academy of Sciences. 1999 Jun 29;877:614–637. doi: 10.1111/j.1749-6632.1999.tb09292.x. [DOI] [PubMed] [Google Scholar]
  • 95.Drevets WC, Videen TO, Price JL, Preskorn SH, Carmichael ST, Raichle ME. A functional anatomical study of unipolar depression. The Journal of neuroscience : the official journal of the Society for Neuroscience. 1992 Sep;12(9):3628–3641. doi: 10.1523/JNEUROSCI.12-09-03628.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Perlman G, Simmons AN, Wu J, et al. Amygdala response and functional connectivity during emotion regulation: a study of 14 adolescents with depression. Journal of affective disorders. 2012 Jun;139(1):75–84. doi: 10.1016/j.jad.2012.01.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Cardinal RN, Parkinson JA, Hall J, Everitt BJ. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neuroscience and biobehavioral reviews. 2002 May;26(3):321–352. doi: 10.1016/s0149-7634(02)00007-6. [DOI] [PubMed] [Google Scholar]
  • 98.Craig AD. How do you feel--now? The anterior insula and human awareness. Nature reviews Neuroscience. 2009 Jan;10(1):59–70. doi: 10.1038/nrn2555. [DOI] [PubMed] [Google Scholar]
  • 99.Carter CS, Botvinick MM, Cohen JD. The contribution of the anterior cingulate cortex to executive processes in cognition. Reviews in the neurosciences. 1999;10(1):49–57. doi: 10.1515/revneuro.1999.10.1.49. [DOI] [PubMed] [Google Scholar]
  • 100.Yang TT, Simmons AN, Matthews SC, et al. Adolescents with depression demonstrate greater subgenual anterior cingulate activity. Neuroreport. 2009 Mar 4;20(4):440–444. doi: 10.1097/WNR.0b013e3283262e10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101.Johansen-Berg H, Gutman DA, Behrens TE, et al. Anatomical connectivity of the subgenual cingulate region targeted with deep brain stimulation for treatment-resistant depression. Cerebral cortex (New York, NY : 1991) 2008 Jun;18(6):1374–1383. doi: 10.1093/cercor/bhm167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Neumeister A, Nugent AC, Waldeck T, et al. Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of general psychiatry. 2004 Aug;61(8):765–773. doi: 10.1001/archpsyc.61.8.765. [DOI] [PubMed] [Google Scholar]
  • 103.Hasler G, Fromm S, Carlson PJ, et al. Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of general psychiatry. 2008 May;65(5):521–531. doi: 10.1001/archpsyc.65.5.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Holthoff VA, Beuthien-Baumann B, Zundorf G, et al. Changes in brain metabolism associated with remission in unipolar major depression. Acta psychiatrica Scandinavica. 2004 Sep;110(3):184–194. doi: 10.1111/j.1600-0447.2004.00351.x. [DOI] [PubMed] [Google Scholar]
  • 105.Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological psychiatry. 2000 Oct 15;48(8):830–843. doi: 10.1016/s0006-3223(00)01036-2. [DOI] [PubMed] [Google Scholar]
  • 106.Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. 2002 Dec;12(6):527–544. doi: 10.1016/s0924-977x(02)00102-5. [DOI] [PubMed] [Google Scholar]
  • 107.Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ect. The American journal of psychiatry. 2001 Feb;158(2):305–308. doi: 10.1176/appi.ajp.158.2.305. [DOI] [PubMed] [Google Scholar]
  • 108.Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. The American journal of psychiatry. 2011 May;168(5):502–510. doi: 10.1176/appi.ajp.2010.10081187. [DOI] [PubMed] [Google Scholar]
  • 109.Holtzheimer PE, Kelley ME, Gross RE, et al. Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Archives of general psychiatry. 2012 Feb;69(2):150–158. doi: 10.1001/archgenpsychiatry.2011.1456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI. NeuroImage. 2002 Jun;16(2):331–348. doi: 10.1006/nimg.2002.1087. [DOI] [PubMed] [Google Scholar]
  • 111.Chen YH, Dammers J, Boers F, et al. The temporal dynamics of insula activity to disgust and happy facial expressions: a magnetoencephalography study. NeuroImage. 2009 Oct 1;47(4):1921–1928. doi: 10.1016/j.neuroimage.2009.04.093. [DOI] [PubMed] [Google Scholar]
  • 112.Zeki S, Romaya JP. Neural correlates of hate. PloS one. 2008;3(10):e3556. doi: 10.1371/journal.pone.0003556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113.Surguladze SA, El-Hage W, Dalgleish T, Radua J, Gohier B, Phillips ML. Depression is associated with increased sensitivity to signals of disgust: a functional magnetic resonance imaging study. Journal of psychiatric research. 2010 Oct;44(14):894–902. doi: 10.1016/j.jpsychires.2010.02.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Dalby RB, Elfving B, Poulsen PH, et al. Plasma brain-derived neurotrophic factor and prefrontal white matter integrity in late-onset depression and normal aging [published online January 27, 2013] Acta Psychiatr Scand. 2013 doi: 10.1111/acps.12085. [DOI] [PubMed] [Google Scholar]
  • 115.George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM. Brain activity during transient sadness and happiness in healthy women. The American journal of psychiatry. 1995 Mar;152(3):341–351. doi: 10.1176/ajp.152.3.341. [DOI] [PubMed] [Google Scholar]
  • 116.Reiman EM, Lane RD, Ahern GL, et al. Neuroanatomical correlates of externally and internally generated human emotion. The American journal of psychiatry. 1997 Jul;154(7):918–925. doi: 10.1176/ajp.154.7.918. [DOI] [PubMed] [Google Scholar]
  • 117.Wang J, Rao H, Wetmore GS, et al. Perfusion functional MRI reveals cerebral blood flow pattern under psychological stress; Proceedings of the National Academy of Sciences of the United States of America; Dec 6 2005; pp. 17804–17809. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Herrington JD, Taylor JM, Grupe DW, Curby KM, Schultz RT. Bidirectional communication between amygdala and fusiform gyrus during facial recognition. NeuroImage. 2011 Jun 15;56(4):2348–2355. doi: 10.1016/j.neuroimage.2011.03.072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Konarski JZ, McIntyre RS, Grupp LA, Kennedy SH. Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? Journal of psychiatry and neuroscience : JPN. 2005 May;30(3):178–186. [PMC free article] [PubMed] [Google Scholar]
  • 120.Schmahmann JD. An emerging concept. The cerebellar contribution to higher function. Archives of neurology. 1991 Nov;48(11):1178–1187. doi: 10.1001/archneur.1991.00530230086029. [DOI] [PubMed] [Google Scholar]
  • 121.Anand BK, Malhotra CL, Singh B, Dua S. Cerebellar projections to limbic system. Journal of neurophysiology. 1959 Jul;22(4):451–457. doi: 10.1152/jn.1959.22.4.451. [DOI] [PubMed] [Google Scholar]
  • 122.Heath RG, Dempesy CW, Fontana CJ, Myers WA. Cerebellar stimulation: effects on septal region, hippocampus, and amygdala of cats and rats. Biological psychiatry. 1978 Oct;13(5):501–529. [PubMed] [Google Scholar]
  • 123.Vilensky JA, van Hoesen GW. Corticopontine projections from the cingulate cortex in the rhesus monkey. Brain research. 1981 Feb 2;205(2):391–395. doi: 10.1016/0006-8993(81)90348-6. [DOI] [PubMed] [Google Scholar]
  • 124.Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain : a journal of neurology. 1998 Apr;121(Pt 4):561–579. doi: 10.1093/brain/121.4.561. [DOI] [PubMed] [Google Scholar]
  • 125.Levisohn L, Cronin-Golomb A, Schmahmann JD. Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain : a journal of neurology. 2000 May;123(Pt 5):1041–1050. doi: 10.1093/brain/123.5.1041. [DOI] [PubMed] [Google Scholar]
  • 126.Liotti M, Mayberg HS, McGinnis S, Brannan SL, Jerabek P. Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. The American journal of psychiatry. 2002 Nov;159(11):1830–1840. doi: 10.1176/appi.ajp.159.11.1830. [DOI] [PubMed] [Google Scholar]
  • 127.Liu CH, Ma X, Li F, et al. Regional homogeneity within the default mode network in bipolar depression: a resting-state functional magnetic resonance imaging study. PloS one. 2012;7(11):e48181. doi: 10.1371/journal.pone.0048181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Guo W, Liu F, Dai Y, et al. Decreased interhemispheric resting-state functional connectivity in first-episode, drug-naive major depressive disorder. Progress in neuro-psychopharmacology and biological psychiatry. 2013 Mar 5;41:24–29. doi: 10.1016/j.pnpbp.2012.11.003. [DOI] [PubMed] [Google Scholar]
  • 129.Liu L, Zeng LL, Li Y, et al. Altered cerebellar functional connectivity with intrinsic connectivity networks in adults with major depressive disorder. PloS one. 2012;7(6):e39516. doi: 10.1371/journal.pone.0039516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Ma Q, Zeng LL, Shen H, Liu L, Hu D. Altered cerebellar-cerebral resting-state functional connectivity reliably identifies major depressive disorder. Brain research. 2013 Feb 7;1495:86–94. doi: 10.1016/j.brainres.2012.12.002. [DOI] [PubMed] [Google Scholar]
  • 131.Mayberg HS, Lewis PJ, Regenold W, Wagner HN., Jr Paralimbic hypoperfusion in unipolar depression. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 1994 Jun;35(6):929–934. [PubMed] [Google Scholar]
  • 132.Aguirre GK, Detre JA, Zarahn E, Alsop DC. Experimental design and the relative sensitivity of BOLD and perfusion fMRI. NeuroImage. 2002 Mar;15(3):488–500. doi: 10.1006/nimg.2001.0990. [DOI] [PubMed] [Google Scholar]
  • 133.Viviani R, Messina I, Walter M. Resting state functional connectivity in perfusion imaging: correlation maps with BOLD connectivity and resting state perfusion. PloS one. 2011;6(11):e27050. doi: 10.1371/journal.pone.0027050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 134.Chuang KH, van Gelderen P, Merkle H, et al. Mapping resting-state functional connectivity using perfusion MRI. NeuroImage. 2008 May 1;40(4):1595–1605. doi: 10.1016/j.neuroimage.2008.01.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 135.Liu J, Hao Y, Du M, et al. Quantitative cerebral blood flow mapping and functional connectivity of postherpetic neuralgia pain: a perfusion fMRI study. Pain. 2013 Jan;154(1):110–118. doi: 10.1016/j.pain.2012.09.016. [DOI] [PubMed] [Google Scholar]
  • 136.Mayberg HS. Modulating limbic-cortical circuits in depression: targets of antidepressant treatments. Seminars in clinical neuropsychiatry. 2002 Oct;7(4):255–268. doi: 10.1053/scnp.2002.35223. [DOI] [PubMed] [Google Scholar]
  • 137.Liu TT, Brown GG. Measurement of cerebral perfusion with arterial spin labeling: Part 1. Methods. J Int Psychol Soc. 2007;23:517–525. doi: 10.1017/S1355617707070646. [DOI] [PubMed] [Google Scholar]
  • 138.Chen Y, Wang DJ, Detre JA. Test-retest reliability of arterial spin labeling with common labeling strategies. Journal of magnetic resonance imaging : JMRI. 2011 Apr;33(4):940–949. doi: 10.1002/jmri.22345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Gevers S, van Osch MJ, Bokkers RP, et al. Intra- and multicenter reproducibility of pulsed, continuous and pseudo-continuous arterial spin labeling methods for measuring cerebral perfusion. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 2011 Aug;31(8):1706–1715. doi: 10.1038/jcbfm.2011.10. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01

Figure S1. Overlap between whole brain results and linear mixed effects modeling results. Note: The linear mixed effects model (see “Linear mixed effects model with anxiety as a covariate” under Method in main text) controlling for anxiety revealed 7 clusters with significantly different regional cerebral blood flow (rCBF) levels in major depressive disorder (MDD) compared with healthy controls (HCL) (see Table S3, available online). Five of these clusters overlapped with the whole brain results: right inferior frontal/dorsolateral prefrontal cortex (73 overlapping voxels), right anterior cingulate cortex (40 overlapping voxels), left insula (22 overlapping voxels), right putamen/lentiform nucleus (18 overlapping voxels), and right cerebellum (16 overlapping voxels), thereby suggesting that anxiety did not drive the differences found in our main findings. BA=Brodmann area; L=left; R=right.

RESOURCES